Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nouveau Life Pharmaceuticals, Inc. (NOUV)
Ft. Lauderdale, FL, US
Nouveau Life Pharmaceuticals, Inc. (NOUV) is a company in its developmental stage, primarily focused on crafting nutraceutical products. It offers both natural health solutions and pharmaceutical drugs. The entity, which began operations in 1998, was previously known as Hybrid Fuels, Inc. before adopting its current designation in May 2012. Based in Ft. Lauderdale, Florida, Nouveau Life Pharmaceuticals, Inc. functions as an affiliate of EMG Marketing Solutions, Inc.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +9,900.00% | +0.00% | -60.00% | -83.33% | -50.00% | -99.94% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Shell Companies: +20.6%—
-
EPS growth Shell Companies: -12.3%+100.0% ★ Q1'25: +100.0% (vs Q4'07)
-
FCF margin FCF growth · Shell Companies: +8.7%—
-
EBIT margin Shell Companies: +0.0%—
-
ROIC Shell Companies: +0.0%— Q1'25: +21.8% (vs Q4'07)
-
Share dilution Shell Companies: -10.2%+23,428.7% Q1'25: +22,020.6% (vs Q4'07)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×— Q1'25: 0.00× (vs Q4'07)
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Brian Shibley | Chairman of the Board, Chief Executive Officer & President | — | male |
| Darcy Penner | Manager of Investor Relations | — | male |
| Douglas Dickie | Chief Financial Officer and Director | — | male |
| Rolly Hein | Acting Vice President and Director | — | male |
| Warren Wheeler | Treasurer, Secretary and Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NOUV
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
